José Eduardo Suárez-Santiago

Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer’s disease

Lina Clara Gayoso e Almendra Ibiapina Moreno, Elena Puerta, José Eduardo Suárez-Santiago et al. · International Journal of Pharmaceutics · 2016 · 164 citations

Nanomedicine, Alzheimer's Disease, Medicine +8

Agonist E-6837 and antagonist SB-271046 of 5-HT6 receptors both reverse the depressive-like effect induced in mice by subchronic ketamine administration

José Eduardo Suárez-Santiago, Alfredo Briones-Aranda, Judith Espinosa‐Raya et al. · Behavioural Pharmacology · 2017 · 20 citations

Antagonist Sb-271046, Psychopharmacology, Pharmacotherapy +18

Magnolia officinalis Reduces Inflammation and Damage Induced by Recurrent Status Epilepticus in Immature Rats

Angélica Vega-García, Luísa Rocha, Rosalinda Guevara‐Guzmán et al. · Current Pharmaceutical Design · 2020 · 11 citations

Repeated ketamine administration induces recognition memory impairment together with morphological changes in neurons from ventromedial prefrontal cortex, dorsal striatum, and hippocampus

José Eduardo Suárez-Santiago, Sandra Orozco‐Suárez, Angélica Vega-García et al. · Behavioural Pharmacology · 2020 · 10 citations